BioVersys (Grant)
Funding Details
- Awarder
- Inbox
- Date Award
- June 09, 2025
- Vertical
- Biotech
- Funding URL
- View Funding Page
- Funding Amount:
- $2,000,000
Company Info
- Traction
- BioVersys has access to approximately €2 million in non-dilutive funding from the original IMI2 RespiriNTM grant of approximately €5.7 million.
- Organizations Involved
- PPP Allowance, Health~Holland, Top Sector Life Sciences & Health
- Company Description
- BioVersys is focused on developing novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The company is part of the EU-funded RespiriNTM programme, which explores new targets for anti-mycobacterial compounds and optimizes novel inhibitors for clinical trials.
- Market
- Healthcare
- Location
- Switzerland